Total Payments
$6,505
2024 Payments
$1,164
Companies
22
Transactions
174
Medicare Patients
2,240
Medicare Billing
$423,113
Payment Breakdown by Category
Food & Beverage$4,612 (70.9%)
Travel$1,893 (29.1%)
Gifts$0.02 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,612 | 167 | 70.9% |
| Travel and Lodging | $1,893 | 5 | 29.1% |
| Gift | $0.02 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $3,120 | 18 | $0 (2022) |
| SCILEX PHARMACEUTICALS INC. | $855.99 | 48 | $0 (2024) |
| ABBVIE INC. | $724.55 | 29 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $450.65 | 32 | $0 (2024) |
| Nevro Corp. | $344.91 | 7 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $230.95 | 7 | $0 (2024) |
| DePuy Synthes Sales Inc. | $163.15 | 4 | $0 (2024) |
| Medtronic, Inc. | $115.39 | 6 | $0 (2023) |
| Azurity Pharmaceuticals, Inc. | $100.65 | 3 | $0 (2024) |
| Hikma Pharmaceuticals USA | $65.17 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,164 | 60 | SCILEX PHARMACEUTICALS INC. ($348.37) |
| 2023 | $921.94 | 42 | Scilex Pharmaceuticals Inc. ($312.77) |
| 2022 | $1,285 | 52 | ABBVIE INC. ($283.27) |
| 2021 | $3,133 | 20 | BOSTON SCIENTIFIC CORPORATION ($2,990) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Analgesic | ||||||
| 12/30/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: Analgesic | ||||||
| 12/19/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $7.31 | General |
| Category: Opioid Analgesic | ||||||
| 12/10/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.42 | General |
| Category: Opioid Analgesic | ||||||
| 12/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Analgesic | ||||||
| 11/26/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Analgesic | ||||||
| 11/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $7.41 | General |
| Category: Opioid Analgesic | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: PAIN | ||||||
| 11/15/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: Opioid Analgesic | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Analgesic | ||||||
| 10/31/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Analgesic | ||||||
| 10/31/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $5.17 | General |
| Category: Opioid Analgesic | ||||||
| 10/31/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $2.10 | General |
| Category: Opioid Analgesic | ||||||
| 10/31/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $1.40 | General |
| Category: Analgesic | ||||||
| 10/23/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.35 | General |
| Category: Opioid Analgesic | ||||||
| 10/22/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/17/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Analgesic | ||||||
| 10/03/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $9.61 | General |
| Category: Opioid Analgesic | ||||||
| 09/26/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Analgesic | ||||||
| 09/26/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: Analgesic | ||||||
| 09/24/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.94 | General |
| Category: Opioid Analgesic | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: PAIN | ||||||
| 09/20/2024 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Sports Early Intervention | ||||||
| 09/17/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: CEREBROVASCULARCNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 662 | 1,701 | $595,990 | $126,387 |
| 2022 | 9 | 672 | 1,703 | $535,564 | $131,363 |
| 2021 | 6 | 595 | 1,388 | $294,300 | $126,154 |
| 2020 | 6 | 311 | 795 | $167,908 | $39,210 |
Total Patients
2,240
Total Services
5,587
Medicare Billing
$423,113
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 293 | 1,019 | $458,550 | $85,861 | 18.7% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 146 | 208 | $72,800 | $23,070 | 31.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 149 | 213 | $40,470 | $12,832 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 47 | $15,040 | $3,031 | 20.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 16 | $3,910 | $788.03 | 20.2% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 12 | 18 | $3,420 | $664.36 | 19.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 180 | $1,800 | $140.76 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 291 | 1,093 | $402,600 | $90,660 | 22.5% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 134 | 182 | $59,300 | $20,518 | 34.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 143 | 199 | $39,960 | $12,181 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 64 | $16,230 | $4,043 | 24.9% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 13 | 13 | $6,009 | $1,998 | 33.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 14 | 21 | $6,015 | $1,058 | 17.6% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 13 | 19 | $4,050 | $711.40 | 17.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 21 | 28 | $560.00 | $121.49 | 21.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 13 | 84 | $840.00 | $71.03 | 8.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 278 | 958 | $191,600 | $88,744 | 46.3% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 131 | 176 | $42,240 | $20,140 | 47.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 133 | 180 | $43,200 | $11,185 | 25.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 39 | $5,850 | $2,616 | 44.7% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 13 | 15 | $5,535 | $2,349 | 42.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 14 | 20 | $5,875 | $1,121 | 19.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 196 | 634 | $143,904 | $34,070 | 23.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 31 | $10,292 | $2,095 | 20.4% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2020 | 14 | 29 | $5,077 | $1,293 | 25.5% |
About Manuel Marquez, FNP
Manuel Marquez, FNP is a Family healthcare provider based in Fairfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1740532977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Manuel Marquez, FNP has received a total of $6,505 in payments from pharmaceutical and medical device companies, with $1,164 received in 2024. These payments were reported across 174 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,612).
As a Medicare-enrolled provider, Marquez has provided services to 2,240 Medicare beneficiaries, totaling 5,587 services with total Medicare billing of $423,113. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Fairfield, CT
- Active Since 10/11/2012
- Last Updated 03/07/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1740532977
Products in Payments
- WAVEWRITER ALPHA (Device) $2,561
- ZTLido (Drug) $790.52
- UBRELVY (Drug) $375.74
- Belbuca (Drug) $258.62
- QUVIVIQ (Drug) $230.95
- GENERAL PAIN MANAGEMENT (Device) $226.10
- Omnia (Device) $217.74
- Superion (Device) $202.99
- XTAMPZA (Drug) $192.03
- Senza (Device) $127.17
- INTELLIS ADAPTIVESTIM (Device) $115.39
- BOTOX (Biological) $115.23
- MONOVISC (Device) $114.47
- Superion Indirect Decompression System (Device) $110.43
- QULIPTA (Drug) $108.57
- HORIZANT (Drug) $100.65
- Kloxxado (Drug) $65.17
- Evoke SCS (Device) $53.55
- ORTHOVISC (Device) $48.68
- RELISTOR (Drug) $37.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Fairfield
Laurie Bresee
Family — Payments: $11,797
Family $11,797
Ayisha Ilias, Fnp-C, FNP-C
Family — Payments: $6,729
Family $6,729
Todd Clark, Aprn, APRN
Family — Payments: $4,297
Family $4,297
Mr. Stephen Rogers, Fnp-C, FNP-C
Family — Payments: $4,208
Family $4,208
Ms. Jillian Ross, A.p.r.n, A.P.R.N
Family — Payments: $3,749
Family $3,749
Julie Crouse, Np, NP
Family — Payments: $2,903
Family $2,903